Halozyme Therapeutics, Inc. (HALO) Revenue History
Halozyme Therapeutics, Inc. (HALO) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $146.69M |
| 2017-12-31 | $316.61M |
| 2018-12-31 | $151.86M |
| 2019-12-31 | $195.99M |
| 2020-12-31 | $267.59M |
| 2021-12-31 | $443.31M |
| 2022-12-31 | $660.12M |
| 2023-12-31 | $829.25M |
| 2024-12-31 | $1.02B |
| 2025-12-31 | $1.40B |
How HALO compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| ADUS | Addus HomeCare Corporation | $1.42B |
| PEN | Penumbra Inc. | $1.40B |
| HAE | Haemonetics Corporation | $1.33B |
| PAHC | Phibro Animal Health Corporation | $1.30B |
| ARRY | Array Technologies Inc. | $1.28B |
These are five companies in the same sector as HALO with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Halozyme Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("HALO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HALO | $108.17 | +1.93% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 |